Prolia (Denosumab) is a treatment used for osteoporosis and reducing the risk of fractures, especially in people at risk of bone loss due to aging, medical conditions, or certain therapies.
What is Prolia (Denosumab)?
Prolia is a biologic therapy that works by inhibiting the activity of cells responsible for bone breakdown.
In osteoporosis, bone density gradually decreases, increasing the risk of fractures. Prolia helps to:
- Reduce bone loss
- Increase bone density
- Lower fracture risk
In simple terms:
It helps protect and strengthen bones.
Indications
Prolia (Denosumab) is used in:
- Postmenopausal osteoporosis
- Osteoporosis in men
- Bone loss associated with certain cancer treatments
- Patients at high risk of fractures
Dosage and Administration
- Standard dose: 60 mg
- Administered as a subcutaneous injection
- Given once every 6 months
- Administered under medical supervision
Common Side Effects
May include:
- Bone or muscle pain
- Joint pain
- Low calcium levels
- Mild infections
- Fatigue
Rarely: jaw problems or unusual fractures requiring close monitoring.
Monitoring During Treatment
Patients on Prolia (Denosumab) require:
- Calcium and Vitamin D monitoring
- Bone density assessment
- Monitoring for new symptoms
- Evaluation of treatment response
Availability & How to Access Treatment
Prolia (Denosumab) is available through Macrocare’s approved partners.
You can now request and access the medication easily through us.
WhatsApp contact for medication requests:
Click here
Prolia (Denosumab) Prolia (Denosumab) 60 mg is an effective osteoporosis treatment that helps strengthen bones, improve bone density, and reduce fracture risk.
Medical Disclaimer:
This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.
